Comprehensive Genomic Profiling in Predictive Testing of Cancer

Somatic Genomic Testing in Patients With Metastatic or Advanced Cancer: ASCO Provisional Clinical Opinion

(2022) Debyani Chakravarty et al.   JOURNAL OF CLINICAL ONCOLOGY

Evolving strategies for management of desmoid tumor

(2022) Richard F. Riedel et al.   CANCER

Expert opinion on NSCLC small specimen biomarker testing — Part 1: Tissue collection and management

(2022) Frédérique Penault-Llorca et al.   VIRCHOWS ARCHIV

Varied histomorphology and clinical outcomes of FGFR3-TACC3 fusion gliomas

(2022) Malcolm F. McDonald et al.   Neurosurgical Focus

Human TERT promoter mutations as a prognostic biomarker in glioma

(2021) Branka Powter et al.   JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY

Unlocking Access to Broad Molecular Profiling: Benefits, Barriers, and Policy Solutions

(2021) David M. Thomas et al.   Public Health Genomics

Bladder cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up

(2021) T. Powles et al.   ANNALS OF ONCOLOGY

Molecular profiling for precision cancer therapies

(2020) Eoghan R. Malone et al.   Genome Medicine

Personalized Medicine: Recent Progress in Cancer Therapy

(2020) Valentina Gambardella et al.   Cancers

Long-term Outcomes of Oral Vinorelbine in Advanced, Progressive Desmoid Fibromatosis and Influence of CTNNB1 Mutational Status

(2020) Olivier Mir et al.   CLINICAL CANCER RESEARCH

Characterizing TP53 mutations in ovarian carcinomas with and without concurrent BRCA1 or BRCA2 mutations

(2020) Talayeh S. Ghezelayagh et al.   GYNECOLOGIC ONCOLOGY

Comprehensive Genomic Profiling of Carcinoma of Unknown Primary Origin: Retrospective Molecular Classification Considering the CUPISCO Study Design

(2020) Jeffrey S. Ross et al.   ONCOLOGIST

Germline-Focused Analysis of Tumour-Only Sequencing: Recommendations from the ESMO Precision Medicine Working Group

(2019) D Mandelker et al.   ANNALS OF ONCOLOGY

OS9.3 Clinical, molecular and radiomic profile of gliomas with FGFR3-TACC3 fusion

(2019) A Picca et al.   NEURO-ONCOLOGY

Spectrum of TERT promoter mutations and mechanisms of activation in thyroid cancer

(2019) Federica Panebianco et al.   Cancer Medicine

Personalized medicine: motivation, challenges, and progress

(2018) Laura H. Goetz et al.   FERTILITY AND STERILITY

Frequency of Somatic TP53 Mutations in Combination with Known Pathogenic Mutations in Colon Adenocarcinoma, Non–Small Cell Lung Carcinoma, and Gliomas as Identified by Next-Generation Sequencing

(2018) Zahra Shajani-Yi et al.   NEOPLASIA

Standards and Guidelines for the Interpretation and Reporting of Sequence Variants in Cancer

(2017) Marilyn M. Li et al.   JOURNAL OF MOLECULAR DIAGNOSTICS

ALKFusions in a Wide Variety of Tumor Types Respond to Anti‐ALK Targeted Therapy

(2017) Jeffrey S. Ross et al.   ONCOLOGIST

Microsatellite Instability

(2017) Liisa Chang et al.   APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY

TP53Variations in Human Cancers: New Lessons from the IARC TP53 Database and Genomics Data

(2016) Liacine Bouaoun et al.   HUMAN MUTATION

HGVS Recommendations for the Description of Sequence Variants: 2016 Update

(2016) Johan T. den Dunnen et al.   HUMAN MUTATION

FGFR3-TACC3 fusion in solid tumors: mini review

(2016) Ricardo Costa et al.   Oncotarget

Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology

(2015) Sue Richards et al.   GENETICS IN MEDICINE

GE-09 * TERT PROMOTER MUTATION, IDH MUTATION AND 1p/19q CODELETION DEFINE FIVE GLIOMA MOLECULAR GROUPS WITH SPECIFIC CLINICAL CHARACTERISTICS AND GERMLINE VARIANT ASSOCIATIONS

(2014) J. Eckel-Passow et al.   NEURO-ONCOLOGY

Poor survival with wild-type TP53 ovarian cancer?

(2013) Kwong-Kwok Wong et al.   GYNECOLOGIC ONCOLOGY

CTNNB1 Genotyping and APC Screening in Pediatric Desmoid Tumors: A Proposed Algorithm

(2012) Wei-Lien Wang et al.   PEDIATRIC AND DEVELOPMENTAL PATHOLOGY

Specific Mutations in the β-Catenin Gene (CTNNB1) Correlate with Local Recurrence in Sporadic Desmoid Tumors

(2008) Alexander J.F. Lazar et al.   AMERICAN JOURNAL OF PATHOLOGY